A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis
Raman Govindrajan
Advertisement
Raman Govindrajan is director and CSO, Samrud Foundation for Health and Research, Bangalore, India.
Articles by Raman Govindrajan
Advertisement
Latest Updated Articles
- A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19
Published: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
